论文信息 - Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer - 字舞流文

Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

F. Moraes | K. Fong | R. Bowman | R. Riera | L. Perry | J. Penny-Dimri | T. B. Castria | D. Ramson | T. B. D. Castria | F. N. Santos